# Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma

> **NCT02176720** · PHASE1 · TERMINATED · sponsor: **The Methodist Hospital Research Institute** · enrollment: 31 (actual)

## Conditions studied

- Glioma
- Glioblastoma
- Glioblastoma Multiforme

## Interventions

- **DRUG:** FDOPA PET

## Key facts

- **NCT ID:** NCT02176720
- **Lead sponsor:** The Methodist Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-05
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** PI left HMRI
- **Last updated:** 2018-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02176720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02176720, "Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02176720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*